Trials / Completed
CompletedNCT02740569
Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 62 (actual)
- Sponsor
- Marmara University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Scleroderma is an autoimmune disease with skin manifestations and may have pulmonary involvement. Obstructive sleep apnea (OSA) may also be seen in scleroderma. Less is known regarding the prevalence of OSA in scleroderma and its association with pulmonary involvement.
Detailed description
Scleroderma is an autoimmune disease with skin manifestations and may have pulmonary involvement. OSA may also be seen in scleroderma. Less is known regarding the prevalence of obstructive sleep apnea in scleroderma and its association with pulmonary involvement. The investigators would like to address the prevalence of OSA in patients with Scleroderma, using overnight cardiorespiratory polygraphy. Other comorbidities and pulmonary findings on computer tomography (CT) as well as lung function tests will be evaluated. The investigators plan to include 60 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Observational study. Intervention according to the clinical routines (not included in this part) |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2016-04-15
- Last updated
- 2018-09-07
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02740569. Inclusion in this directory is not an endorsement.